Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Family-focused budgeting tips to allocate funds transparently, assign roles, and keep everyone aligned with collective financial goals.
20,074 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Genius Sports reported a significant top-line gain, with revenue up sharply last quarter. But a prominent investor ch...
Lucid represents a high-risk, high-reward bet in the EV space. Before you consider investing, these three practical f...
Investors eyes turn to NextNav as 2025 earnings loom. This guide breaks down what to watch, potential growth drivers,...
As markets weigh the politics of a Trump-backed Fed chair, investors need a plan. This opinion piece breaks down pote...
GlobalFoundries stock skyrocketed this week as quantum computing initiatives and government backing boosted optimism....
Bitcoin stalls near $77K as AI-focused Worldcoin jumps 25% in a single session, highlighting a split in crypto market...
As mega-cap tech valuations wobble, a rare under-$30 stock with solid cash flow and a growing media footprint stands ...
An insider at Mirion Technologies reduced his stake by roughly $165,000 in a May 2026 move. This article explains how...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...
Investors are asking if sofi stock finally bottomed? This guide breaks down the signals, what the data actually shows...
A disciplined, long-term plan can turn $1,000 into meaningful gains with AI-driven leaders. Explore three core stocks...